The functional diversity of proteins is a major factor determining the complexity of cells and tissues. Both translational and post-translational modifications contribute to this diversity. Recently, protein unfolding and refolding has been recognised as another mechanism for diversity by unmasking buried or cryptic sequences (epitopes) that possess physiological functions. In the current review, we focus on extracellular proteins where folding dynamics can be influenced by mechanical forces, protein-protein interactions and denaturation. Many cryptic epitopes in these proteins are exposed following proteolytic cleavage, but recent data indicate that unfolding/refolding play an important role in regulating the physiological behaviour of extracellular proteins. By understanding how and when hidden sequences are exposed, novel techniques for manipulating the function of these proteins may be uncovered.
Introduction
Proteins are essential to all aspects of cellular function. They catalyse enzymatic reactions, regulate gene expression and ion transport, communicate between the extracellular environment and the intracellular space, control the structure, shape and mobility of cells, and modulate the movement of cells within tissues. A single gene can encode a protein with diverse functions depending on various events such as alternative splicing, post-translational modifications and compartmentalisation. Some proteins perform multiple tasks that are mechanistically distinct (moonlighting). For example, pyruvate kinase carboxylates pyruvate but, in some species, it also acts as a transporter for other proteins (Ozimek et al., 2003) . Similarly, cytochrome C participates in mitochondrial electron transport but, in the cytosol, it forms a complex with Apaf-1 to initiate apoptosis (Hao et al., 2005) . There are numerous examples of these multi-purpose proteins (Huberts and van der Klei, 2010) . The different translational and post-translational modifications that a protein can undergo gives rise to functional diversity that contributes to the biological complexity of cells and tissues. In recent years, subtle changes in protein structure due to induced unfolding and refolding has been recognised as a further contributor to this functional diversity (Uversky, 2015) .
The vast array of functions that proteins perform is enabled by the precise folding of an amino acid sequence into a specific but dynamic three-dimensional conformation. Differences between structural elements distinguish one protein from another and represent the most fundamental property affecting the biological activity of proteins. Correct biological functionality requires a protein to exist in its native conformation. Misfolding can lead to proteopathy, diseases caused by protein aggregation, which include amyloidosis, Alzheimer's disease, amyotrophic lateral sclerosis, tauopathies, retinitis pigmentosa, Huntington's disease and Parkinson's disease.
Proteins are structurally dynamic with ordered and disordered regions that unfold and refold over time and in response to various stimuli (Jakob et al., 2014) . It has been widely reported that changes in the folding state of a protein can expose functional domains normally hidden or shielded within the protein. This has been best illustrated by antibody recognition of various antigenic determinants (epitopes) in misfolded proteins (Sela-Culang et al., 2013) . Epitopes can be specific sequences (linear peptides) or motifs comprised of several structural elements in close proximity. Upon unfolding of a protein, the antigenic site (cryptic epitope) is exposed and elicits an immunological reaction (Laver et al., 1990) . This is the basis for many auto-immune diseases. For example, the plasma transport protein transthyretin is involved in several forms of amyloidosis. Following unfolding and aggregation of transthyretin (Goldsteins et al., 1999; Phay et al., 2014) , a normally buried -strand is exposed (Gustavsson et al., 1994) . Moreover, antibodies to this -strand are common in patients with transthyretin amyloidosis but not in controls. The influenza coat protein hemagglutinin is another well-characterised example of a molecule that partially unfolds in order to elicit a biological effect, in this case, fusion with the endosomal membrane during infection (Huang et al., 2003) .
While our understanding of cryptic epitope recognition by antibodies is well established, recently evidence has begun to emerge that similar hidden sequences responsible for non-antigenic biological activities are present in some proteins. This is particularly evident in extracellular matrix proteins (Schenk and Quaranta, 2003) where exposure of these buried motifs, referred to as 'matricryptic' sites, involves conformational changes and/or proteolytic cleavage (Davis et al., 2000) . Some of these are central to the primary role of the protein while others create novel functions that are not obvious unless the buried peptide sequence is exposed. These cryptic epitopes increase the functional diversity of many extracellular and intracellular proteins (Fig 1) . The difficulties in identifying functional cryptic epitopes are well reported but recent studies into the effects of protein binding to nanomaterials suggest a model for partially unfolding proteins that can be used to study their altered biological effects (Deng et al., 2011; Mortimer et al., 2014) . The current review briefly summarises recent advances in our understanding of functional diversity focussing on key extracellular proteins.
Learning from extracellular matrix proteins: Matricryptic sites
Extracellular matrix proteins commonly carry out multiple and diverse biological functions, many of which are the result of cryptic site exposure (Maquart et al., 2004) . Although these masked sequences can be activated following either proteolytic cleavage or conformational modifications (Davis et al., 2000; Tran et al., 2005) , discussion here will focus on the latter. Readers are directed to other reviews that cover examples of cryptic sites in extracellular matrix proteins revealed by enzymatic digestion (Davis et al., 2000; Schenk and Quaranta, 2003) . Exposure of bioactive sites by conformational modifications can be induced by several different mechanisms including mechanical force (Hocking et al., 2008) , heterotypic binding to other molecules (Dardik and Lahav, 1999) , selfassembly reactions (Mao and Schwarzbauer, 2005; Wierzbicka-Patynowski and Schwarzbauer, 2003) , and denaturation. The unmasking of cryptic epitopes by molecular stretching has been well characterised for intracellular proteins such as talin and alpha-catenin (del Rio et al., 2009; Yonemura et al., 2010) .
An important point for consideration regarding cryptic sites in extracellular matrix proteins is the gain in functionality. This is highlighted in work linking matricryptic site exposure and cell responses following tissue injury (Davis, 2010) . Matricryptic sites can also be similar to those of pattern recognition receptors. For instance, DMBT1 (a basement membrane matrix protein also referred to as hesin) binds polyanionic ligands including LPS in a similar manner as scavenger receptors (End et al., 2009) . It has been proposed that unmasking of these site that engage pattern recognition receptors helps regulate cell responses during tissue injury (Davis, 2010).
Collagen
Collagens are the most abundant proteins in the extracellular space involved in the organisation of the structural support to surrounding cells throughout the body (Di Lullo et al., 2002) . Collagen has multiple diverse biological effects such as inhibition of angiotensin 1-converting enzyme (ACE), anti-angiogenesis activity, tumor growth inhibition, chemotaxis and oxidative stress relief (Banerjee et al., 2015) . Cryptic binding sites contribute substantially to this functional diversity. The majority of these sites require proteolytic activation (Marneros and Olsen, 2001; Sasaki et al., 2002) . However, conformational changes to collagen can also expose hidden binding domains. For instance, the pro-angiogenic HUIV26 cryptic epitope within the triple helix of collagen IV can be exposed by temperature-induced unfolding (Hangai et al., 2002; Xu et al., 2001) as well as ionizing radiation (Brooks et al., 2002) . This motif has been linked to several biological effects of collagen, including cell migration, adhesion and angiogenesis (Favreau et al., 2014; Xu et al., 2001) . Despite attempts to identify the HUIV26 epitope, the amino acid sequence remains unknown suggesting it may represent a non-contiguous binding domain. Importantly, this epitope has been shown to have a role in tumour metastasis and may be a novel target for drug development (Roth et al., 2006) .
Mechanical forces transmitted across the collagen molecule can lead to localized unfolding (micro-unfolding) (Bourne et al., 2014) . In one domain of the protein, located in the N-terminus of the alpha1 chain, mechanical force exposes a chymotrypsin cleavage site. Mutations in this region, as seen in Ehlers-Danlos syndrome and osteogenesis imperfecta, significantly alter the unfolding kinetics of the collagen molecule (Makareeva et al., 2006) . Tissue injury and remodelling of extracellular proteins can also result in conformational changes in this region of the collagen protein (Leikina et al., 2002; Persikov and Brodsky, 2002) .
Collagen is known to bind to cellular integrins via a cryptic epitope. This tripeptide sequence (arginine-glycine-aspartate or RGD) is exposed when collagen unfolds or is denatured (Engvall et al., 1978; Ingham et al., 1985) . The RGD epitope plays a central role in the function of collagen as a cell signalling molecule and regulates cell proliferation and differentiation (Taubenberger et al., 2010) . In MC3T3-E1 cells, partially denatured collagen engages α5β1-and αv-integrins to promote phosphorylation of focal adhesion kinase (FAK), which eventually stimulates cell differentiation. Unfolding has also been shown to transform collagen type I from a β1 integrinassociated ligand to an αvβ3-dependent ligand due to exposure of an RGD epitope (Davis, 1992; Montgomery et al., 1994) . A similar pathway has been identified for collagen-stimulated endothelial cell proliferation in angiogenesis (Ames et al., 2015) .
Clearly, the collagens are multi-function proteins that play an important role in the remodelling of the extracellular matrix. Much of the diversity seen with the protein originates from cryptic epitopes that bind to a variety of proteins and receptors once the collagen molecule is partially unfolded.
Fibronectin
Two forms of fibronectin mediate a diverse array of biological effects. While the plasma form is involved in coagulation, most fibronectin functions are attributed to the less-soluble cellular form that interacts as part of the extracellular matrix. These functions include cell adhesion, growth, migration and differentiation as well as tissue responses to wound healing, malignant transformation, inflammation and haemostasis. There are various matricryptic sites within fibronectin, the majority of which are exposed following proteolysis (see Table 2 in Schenk et al.) (Schenk and Quaranta, 2003) . However, there is evidence for unmasking of cryptic epitopes by partial unfolding. For example, incorporation of fibronectin in the extracellular matrix occurs by fibrillogensis, which involves self-association (polymerisation) of fibronectin into fibrils. Some of the sites mediating self-association are cryptic or partially cryptic and require conformational changes (such as mechanical stretching) to enable accessibility. Cell-driven increase in tension leads to unfolding and extension of the Fn III modules of the protein exposing cryptic polymerisation sites (Hao et al., 2005) . Controlled strain experiments on fibronectin fibers show that stretch-induced exposure of cryptic sites increases gradually over the full range of fiber extension. This is accompanied by the onset of Fn III module unfolding (Klotzsch et al., 2009 ). The ability of fibronectin to unfold and reveal these sites is attributed to a lack of disulphide bonds in the Fn III modules, which imparts structural flexibility (Ohashi and Erickson, 2011) . A partially cryptic disulphide isomerase activity has also been suggested in the C-terminal FnI12 module that may catalyse the cross-linking of disulphide bonds. This intrinsic rearrangement then facilitates the incorporation of fibronectin into the extracellular matrix (Langenbach and Sottile, 1999) .
Laminin
The laminins are a large family of matrix proteins that regulate cell adhesion, migration, proliferation and differentiation. They are heterotrimeric proteins with at least 15 different isoforms (DeBiase et al., 2006) . Like many other extracellular matrix proteins, laminin is prone to unfolding under mechanical stress. Using atomic force microscopy, Nemes and colleagues demonstrated a stepwise progression in laminin unfolding indicative, but not proof, of a modular structure to the protein (Nemes et al., 2002) . Temperature-dependent unfolding of laminin has been widely reported and used to study its secondary structure. Brooks' group used this approach to map cryptic epitopes within the molecules by screening for synthetic peptides that bound to the unfolded protein (Akalu et al., 2007) . The epitope recognised by the peptide was selectively exposed in melanoma tumor tissue but not in normal tissue. Importantly, blockade of the cryptic site in the tumor tissue led to attenuation of angiogenesis, tumor growth and metastasis. These findings not only suggested that laminin unfolds under physiological conditions but that the exposed cryptic epitopes following unfolding are central to tumorigenesis, at least for the melanoma model used in the study.
Proteins not associated with the Extracellular Matrix

Vitronectin
The glycoprotein vitronectin is found in the circulation and has been associated with a range of functions including complement activation, coagulation and cell adhesion. The molecule exists is several conformational states depending on its degree of unfolding. Native monomeric vitronectin interacts with thrombin-antithrombin complexes and glycoprotein IIb/IIIa while the unfolded multimeric form binds to -endorphin, PAI-1, urokinase receptor and collagen (Seiffert and Smith, 1997 ). This appears to be mediated through the somatomedin B domain in the N-terminal of the protein (Zhou, 2007) . The native form does not bind integrins because the required RGD domain of vitronectin is buried adjacent to its N-terminal. Thus, perturbation of this region of the protein may expose the cryptic RGD site. Indeed, Seiffert and Smith have reported that PAI-1 binding to vitronectin activates the protein to recognise integrins (Seiffert and Smith, 1997) .
Understanding cryptic epitopes not only reveals the intriguing functional diversity of proteins but also may identify potential drug targets. This is demonstrated with both laminin as described above and with vitronectin. Subtractive phage display technology has been used to identify antibodies that selectively bind to the unfolded active form of vitronectin but not to the native form (Bloemendal et al., 2004) . Selectivity was demonstrated with intense immunostaining for the unfolded vitronectin in tumor tissue but not in normal tissue.
Fibrinogen
Fibrinogen is another extracellular protein that illustrates the role of cryptic sites. Of its multiple biological functions, clot formation is considered its primary role in vivo. Secondary physiological processes involve initiating, monitoring and managing inflammatory responses. Fibrinogen is a dimer comprised of three protein chains (α, β, and γ) containing three major structural regions: two D domains at the terminal ends of the chains and a centrally located E domain (Fig 2A) . Conversion of fibrinogen to fibrin, a crucial event leading to exposure of these sites, occurs by thrombin-mediated removal of two pairs of fibrinopeptides (fibrinopeptides A & B) from the central region of the protein. This creates new N-terminal regions with exposed polymerisation sites required for the assembly of fibrin polymers in clot formation (Fig 2B) .
Thrombin cleavage alters the folded state, or secondary structure of the protein, which results in exposure of multiple sites that bind proteins and cells. Binding sites in the D region for plasminogen and tPA (Aα148-160 and γ312-324) have been described that are functional in fibrin but not fibrinogen. This was shown by the lack of binding by monoclonal antibodies raised specifically for each site (Schielen et al., 1991; Schielen et al., 1989) . The sites were masked in fibrinogen and were exposed as a result of intermolecular interaction between the D and E region upon fibrin formation. Using a number of fibrinogen and fibrin derived fragments, it was shown that only D region fragments corresponding to their fibrin converted form bound plasminogen, tPA and monoclonal antibodies for these sites. In addition, binding occurred in fragments forming the intermolecular interaction between the D and E regions, but not upon their dissociation. This showed that a change in conformation of the D region upon interaction with region E made the binding sites accessible (Yakovlev et al., 2000) .
Conformational dependent cryptic sites are also found in other areas of the protein. As well as the three major domains comprising fibrinogen, there are also two compact surface associated regions called the αC-domains that interact with each other intramolecularly (Medved et al., 1985) . Electron microscopy experiments showed that, upon fibrin formation, the conformation of the αC-domains changes so that they dissociate and interact intermolecularly rather than intramolecularly (Gorkun et al., 1994; Veklich et al., 1993) . The intermolecular interaction of the αC-domains then promotes the formation of thicker aggregated fibers required for clotting. This inter to intramolecular switch has also been shown to unmask sites within the αC-domains that bind plasminogen and tPA. As described for the D region, these sites only become accessible upon fibrinogen conversion to fibrin (Medved et al., 2001 ). Since fibrinogen does not bind tPA or plasminogen, these sites are cryptic in the fibrinogen αC-domains and only become available when the domains switch to their physiologically active conformation upon fibrin assembly (Tsurupa et al., 2011) .
The list of cryptic binding sites within fibrinogen continues to expand. Similar binding studies using recombinant fragments along with ELIZA and surface plasmon resonance studies have more recently identified cryptic sites for alpha(2)antiplasmin in the D-region and C-terminal region of the αC-domain (Tsurupa et al., 2010) , as well as a cryptic site for apolipoprotein(a) in the αC-domain of fibrinogen (Tsurupa et al., 2003) . Fibrinogen also contains a cryptic integrin binding site located in the γC region of the D domain (Altieri et al., 1993; Lishko et al., 2004) . Removal of the C-terminal tail of this region exposes the αMβ2 site (Mac-1) for binding to the Mac-1 receptor (Lishko et al., 2002) . The interaction of the Mac-1 site with its corresponding receptor on cells induces a pro-inflammatory response. Importantly, access to the αMβ2 binding site has been shown to occur upon proteolytic cleavage of this tail or upon surface-induced immobilisation of fibrinogen (Lishko et al., 2002) . This suggests that the masking of the αMβ2 binding site by the C-terminal tail can be removed by proteolysis or by conformational alteration. These observations together with the conformational flexibility exhibited by this C-terminal region (Mosesson et al., 2001; Yee et al., 1997) , has lead to a C-terminal "pull out" hypothesis (Yakovlev et al., 2000) . Yakovlev and colleagues' proposal articulates how this conformational transition could control access of ligands to several fibrinogen binding sites and thus regulate the functional interactions of fibrinogen.
Many nanomaterials bind fibrinogen including metal oxides (Canoa et al., 2015; Deng et al., 2009) silicates (Marucco et al., 2014) , gold nanoparticles (Deng et al., 2013; Deng et al., 2012) , carbon black (Kendall et al., 2011) , polymeric spheres (Cedervall et al., 2007) , and single-walled carbon nanotubes (Song et al., 2006) . In addition, fibrinogen is a commonly reported constituent of the 'hard corona' of nanoparticle-protein complexes following exposure to biological environments (Aggarwal et al., 2009; Karmali and Simberg, 2011) . Binding of proteins to nanomaterials is often associated with partial unfolding. This has been demonstrated for fibrinogen where its interaction with polymer-coated gold nanoparticles led to the unfolding of the γC region of the D-domain resulting in the exposure of the peptide sequence that binds to the Mac-1 receptor (Deng et al., 2011) . The extent of unfolding was dependent on the size of the nanoparticle as well as its charge (Deng et al., 2013) . Moreover, other nanomaterials have been shown to elicit the same response (Deng et al., 2011) . These observations are important as they provide a possible mechanistic basis for the inflammatory properties of some nanomaterials. However, they also suggest that precisely engineered nanoparticles may be a useful tool to identify and characterise cryptic epitopes in proteins associated with their surfaces. This principle has also been demonstrated with albumin, as outlined below.
Albumin
Albumin consists of a single polypeptide chain of 585 amino acids and is produced by the parenchymal cells of the liver. It is one of the few non-glycosylated serum proteins and the most abundant, constituting ~50% of the blood plasma volume. Albumin has been studied extensively due to its ability to reversibly bind and transport a vast array of molecules throughout the body, and hence influence multiple biological systems (Peters and Stewart, 2013) . Albumin has several physiological functions, driven principally by its colloidal properties (Kragh-Hansen, 2013) . Its primary function is to regulate blood volume by maintaining the colloid osmotic pressure of the blood compartment. It also influences fluid distribution of tissues providing 75% of the intravascular oncotic pressure (Doweiko and Nompleggi, 1991) . Additional functions include a role in acid-base physiology owing to its 16 histidine imidazole residues (Agrafiotis et al., 2014; Watson, 1999) , anti-oxidant properties by neutralising oxygen radicals (Anraku et al., 2013; Bruschi et al., 2013; Iwao et al., 2012) , anticoagulation properties (Galanakis, 1992; Stoffersen, 1979, 1980) , and the binding and transport of ligands (Anand and Mukherjee, 2013; Dalvit et al., 2002; Sarver et al., 2005) .
The ability to unfold and refold (i.e conformational flexibility) is built into the structure of albumin so that it may alter its shape in response to changes in its environment (Kragh-Hansen et al., 2013) . This allows albumin to bind many substances and operate as an excellent molecular chaperone (Anand and Mukherjee, 2013). The three-dimensional structure of albumin is often referred to as a globular heart-shape consisting of 3 homologous domains. These are subdivided into 2 contiguous helical subdomains A and B (Kragh-Hansen, 2013). The folding flexibility of albumin has been attributed to proline residues located between the subdomains that allow movement of one subdomain relative to another (Brown, 1976) . Molecular flexibility also extends to the hydrophilic surface of the protein allowing a vast array of small molecules to bind. Because of the flexibility between subdomains, small molecule binding alters the spatial orientation between the subdomains which in turn affects the accessibility of other molecules for their binding sites (Quinlan et al., 2005) .
The high internal mobility of albumin also controls exposure of a cryptic epitope that provides anti-apoptotic protection to the endothelium (Bolitho et al., 2007) . CNBr fragmentation of human serum albumin (HAS) was shown to significantly increase this anti-apoptotic activity, which is distinct from the known Cys 34 radical scavenging mechanism. Conformational change of native albumin is required for exposure of the cryptic site, which is demonstrated by the ability of glycosylated HSA to inhibit the anti-apoptotic activity (Zoellner et al., 2009 ). The structural modifications produced in glycosylated HSA limit the high intramolecular flexibility of albumin, thus preventing cryptic site exposure.
Chemically-modified albumin is targeted to cell surface scavenger receptors where it is cleared from the circulation (Mikulikova et al., 2005) . The major scavenger receptor involved appears to be SR-B1 (Binder et al., 2012; Miyazaki et al., 2002) . The exact mechanism remains to be determined, but may involve the modified region of the protein or unfolding induced by the covalent binding of the chemical to the protein. Native albumin is not a ligand for the scavenger receptor family. By contrast, native albumin bound to the surface of various nanomaterials is recognised by scavenger receptors. It was initially suspected that nanoparticle bound albumin was 'structurally damaged' (Dutta et al., 2007) . However, more recent studies have shown the unfolding of albumin is a critical step. Studies by Mortimer et al. (Mortimer et al., 2014) and Fleisher et al. (Fleischer and Payne, 2014) demonstrate that changes to the secondary structure of albumin due to nanoparticle binding directs recognition by receptors and hence uptake into cells. Anionic polystyrene nanoparticles bound with albumin were internalised by albondin expressing cells, while cationic nanoparticles bound albumin and were taken up by scavenger receptor expressing cells (Fleischer and Payne, 2014) . Mortimer and colleagues show that the binding of albumin to anionic layered silicate nanoparticles targets the nanoparticle-albumin complex to scavenger receptors (Mortimer et al., 2014) . Circular dichroism demonstrated how the loss of helical content (i.e change in secondary structure) controls the recognition of complexes by scavenger receptors. Much work has been done at the molecular level to characterise the binding sites of albumin for various molecules as well as how the binding of these molecules alters structural conformation and functionality of the protein . Changes in protein conformation can be accompanied by the exposure of new peptide sequences. As pointed out by Fleisher et al., separating epitope exposure from altered protein conformation is difficult. Mortimer et al. addressed this by showing that an alternate process to nanoparticle-induced unfolding of albumin, heat denaturation, could similarly expose an epitope that bound to scavenger receptors. Furthermore, separate expression of each of the three albumin domains revealed that domains I and II were recognised by scavenger receptors to a greater extent following either heat denaturation or binding to nanoparticles. These insights suggest that the well-known clearance of structurally damaged albumin from the circulation by macrophages is a result of cryptic epitopes designed to be detected by specific changes in protein structure. That the structural changes must be specific are highlighted by the fact that not all foreign material that binds albumin leads to scavenger receptor recognition, as Fleisher et al. demonstrated by the unaltered secondary structure of albumin following binding to anionic polystyrene particles.
These findings indicate that the unfolding dynamics of albumin upon interaction with various surfaces serves to expose hidden epitopes, expanding the functionality of albumin to include a means of clearing various particles from the circulation via the scavenger receptor system. This example also demonstrates how cryptic site exposure operates in conjunction with related pattern recognition receptors to regulate cell responses -a proposal put forward by Davis et al. for extracellular matrix proteins and the recognition of matricryptic sites by pattern recognition receptors involved in tissue injury responses (Davis, 2010) .
Complement Factor H
Complement factor H is a 150 kDa glycoprotein of the complement control protein superfamily (Perkins et al., 2010) . It is included in this review because it has several binding sites for different ligands whose accessibility is dependent on unfolding of the protein. The molecule consists of 20 complement control protein domains connected by short linkers of 3-8 amino acid residues. Complement control protein domains enable folding flexibility that control interactions with other proteins and hence functionality (Okemefuna et al., 2009; Oppermann et al., 2006) . Factor H functions as a complement regulator essential for controlling complement activation in plasma and on cell surfaces (Perkins et al., 2010) . Complement is part of the innate immune system that provides a defence mechanism against pathogens such as bacteria. Complement activation can be initiated by three pathways: the classical, lectin or alternative pathways. The cascading events in each of these pathways ultimately generate the central complement component, C3 convertase, which produces C3b molecules (Ricklin et al., 2010) . Factor H has the critical role of regulating C3b so that host protection against pathogens occurs without C3b over-activated damage to host cells (Bajic et al., 2015) . Factor H controls C3b activity by inhibiting binding of components with C3b and by participating in its inactivation through proteolytic cleavage. Factor H presents five major ligand interactions that influence its complement regulatory activity, recently reviewed by Miller and colleagues (Perkins et al., 2012) . The ligands include C3b, C3d, heparin, C-reactive protein, zinc and itself by self-association. There are 2 binding sites for each ligand except zinc which has several weak interaction sites. In addition, a third binding site for C3b has been proposed (Schmidt et al., 2008) . Binding of heparin, C3d and C-reactive protein to Factor H regulates complement activation at host cell surfaces whereas zinc binding inhibits the regulatory activity of Factor H by promoting its aggregation (Perkins et al., 2012) . Importantly, these binding sites are cryptic within Factor H, requiring specific conformational arrangement of the protein to enable accessibility (Morgan et al., 2011) . A model of Factor H unfolding depicts the native protein as a compact structure with only the C-terminal domain binding sites for C3b, C3d and heparin accessible. Binding of ligands to the C-terminal domain initiates unfolding, exposing additional sites that facilitate further ligand binding and alteration in conformation (Oppermann et al., 2006) .
Bacterial proteins such as PspC from Streptococcus pneumoniae bind with high affinity to Factor H and induce a conformational change that exposes a second cryptic binding domain for the C3b fragment of C3 (Herbert et al., 2015) . The resulting complex enhances the functionality of Factor H as a suppressor of the complement system.
Cryptic epitopes and evolutionary conservation
Functional epitopes, whether explicitly displayed on the surface of a protein or hidden within its structure, may show evolutionary conservation if they are important for the physiological role of the protein. However, identifying these epitopes can be challenging depending on whether they are represented by a linear peptide sequence or a motif involving structural elements in close proximity. An excellent example of cryptic structural motifs with evolutionary conservation is the regions within the HIV-1 envelope glycoprotein that mediate cellular interactions required to infect target cells. These regions or epitopes provide the attachment and fusion points to target cells and hence are resistant to variation by selective pressure . Therefore the virus evolved the cryptic nature of these epitopes as a protective mechanism. This is shown by the conformational flexibility of the structures containing the binding regions that keep the sites hidden and only become accessible following certain sequential interactions (Rizzuto et al., 1998; Sullivan et al., 1998; Wu et al., 1996) . Additional crypticity is provided by variable loops that mask these regions (Lusso et al., 2005; Wyatt et al., 1995) as well as considerable surface glycosylation to evade epitope recognition by the immune system .
Between species, protein homology is highest in those regions of functional importance as structural homology often parallels sequence homology (Schmitt et al., 2002) . By contrast, regions of proteins that are buried tolerate lower sequence similarity so long as structure is maintained. Thus, buried sequences of high homology infer a physiological function. For cryptic epitopes, or matricryptic sites, that are linear and physiologically relevant, evolutionary conservation would be expected. This is demonstrated with the amino acid sequence in the γC region of the fibrinogen molecule that engages the Mac-1 receptor (Deng et al., 2011) . The epitope is exposed following local unfolding. Alignment of the fibrinogen C chain from 15 vertebrate species shows greatest homology (>90%) at the sequence for the Mac-1 receptor binding epitope (Fig 3A) . By contrast, homology is markedly lower in the flanking regions. This is an interesting observation that supports a physiological role for the cryptic epitope, as opposed to an aberrant response to protein unfolding. While evolutionary conservation does not prove that a buried region in a protein may have an effect if exposed, it does provide leads when the tools for discovering such sequences are lacking. When it was discovered that albumin could unfold and recognise the scavenger receptor, the binding epitopes were not specifically identified but several regions were suggested based on their anionic properties -amino acids 56-63, 249-256 and 292-301 (Mortimer et al., 2014) . Alignment of these regions from 17 different vertebrate species (Fig 3B) shows good homology in the first sequence (85-90%), excellent homology in the second sequence (95-100%), but poor homology in the third sequence (~ 70%). This bioinformatics approach, in combination with site-directed mutagenesis, may assist in identifying potential cryptic epitopes in the future.
Nanoparticles and protein unfolding
Nanoparticles possess many unique properties that are the basis for their novel uses in engineering, product development, material science and medicine. For nanoparticles intended for medical applications, protein binding to their surface is well recognised as a major limitation. Surface-bound proteins not only alter the essential properties of the nanoparticles but can also determine their fate in vivo (Butcher et al., 2016; Hadjidemetriou et al., 2015; Sahneh et al., 2015; Schottler et al., 2016) . However, as discussed above with fibrinogen and albumin, nanoparticles may provide a useful tool to identify and characterise cryptic epitopes in many different proteins. This concept was first proposed by Lynch et al (Lynch et al., 2006) and is dependent on the surface curvature and composition of the nanoparticle. As proteins bind, they can spread across the nanoparticle surface. While this results in a corona of protein adhering to the nanoparticle surface, it can also result in protein unfolding and exposure of cryptic epitopes. Proteins bound to nanoparticles often exhibit characteristics not normally associated with them, such as aggregation, receptor interaction and immunogenicity (Monopoli et al., 2012) . When bound proteins are transformed into ligands for specific cell-surface receptors to which they do not normally interact, then the unfolding process on the surface of the nanoparticle is likely to have revealed a cryptic epitope. This has been the explanation for the binding of fibrinogen to the Mac-1 receptor and albumin to the scavenger receptor when associated with nanoparticles (Deng et al., 2011; Mortimer et al., 2014) .
Aggressive unfolding of many proteins exposes internal hydrophobic domains that cause rapid aggregation in an aqueous environment. When this occurs in vivo, toxic amyloidosis can result. Proteins such as b2-microglobulin aggregate following unfolding on various nanoparticle (Linse et al., 2007) . However, with precisely engineered particles with different sizes and surface potentials, it may be possible to screen for epitopes by inducing more subtle unfolding. This was elegantly demonstrated with the partial unfolding of transferrin bound to polystyrene nanoparticles (Kelly et al., 2015) . The challenge is to develop appropriate screening techniques that can identify functional epitopes following unfolding.
Conclusions
The identification of physiologically functional cryptic epitopes is increasing in the literature both for extracellular and intracellular proteins. The unfolding or conformational change required to unmask these epitopes is a process distinct from the more commonly described proteolytic cleavage mechanism. Unfolding is an important feature relevant to protein functionality because it can allow for refolding dynamics that cleavage events cannot. Furthermore, protein unfolding/refolding provides a crucial way of regulating the functionality of proteins and hiding biological activity until it is required. The extent to which a cryptic site is masked (i.e. the amount of folding required to keep it hidden) may also control biological activity. These factors may control the conformation constraints upon the secondary structure thus contributing to the extent to which a hidden site may be buried. There is also evidence to suggest that binding sites can be hidden as opposed to exposed upon unfolding.
There are many questions that need answering to further our knowledge in this field. Importantly, the experimental tools that will allow for the identification of important sites still need to be developed. The examples of nanoparticle induce-unfolding discussed in this review present the opportunity for using nanoparticles as a tool to study proteins and how they unfold in different environments. Using nanomaterials in this way is a more sophisticated and subtle method of providing an environment to induce unfolding than surface immobilisation or heat denaturation which can influence the entire protein. (Mortimer et al., 2014) . Two of these sequences (Albumin I: 56-63, Albumin II: 249-256) show high conservation between 17 vertebrate species while the third (Albumin III: 292-301) does not.
